These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 1814762)

  • 1. Cholecystokinin octapeptide and caerulein injection into the dorsomedial nucleus accumbens potentiate apomorphine-induced jaw movements in rats.
    Koshikawa N; Kikuchi de Beltrán K; Saigusa T; Kobayashi M; Stephenson JD
    Eur J Pharmacol; 1991 Dec; 209(1-2):75-80. PubMed ID: 1814762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dorsal striatal mechanisms involved in the dopamine D2 receptor-mediated potentiation of apomorphine-induced jaw movements.
    Kikuchi de Beltrán K; Koshikawa N; Miwa Y; Kobayashi M
    Eur J Pharmacol; 1994 Jan; 252(1):99-104. PubMed ID: 7908646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dopamine D-1 but not D-2 receptor stimulation of the dorsal striatum potentiates apomorphine-induced jaw movements in rats.
    Koshikawa N; Tomiyama K; Omiya K; de Beltrán KK; Kobayashi M
    Eur J Pharmacol; 1990 Mar; 178(2):189-94. PubMed ID: 1970305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clozapine injected into the nucleus accumbens potentiates apomorphine-induced jaw movements.
    de Beltrán KK; Koshikawa N; Miwa Y; Kobayashi M; Cools AR
    Eur J Pharmacol; 1994 Sep; 262(1-2):49-54. PubMed ID: 7813578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of intrastriatal injections of selective dopamine D-1 and D-2 agonists and antagonists on jaw movements of rats.
    Koshikawa N; Aoki S; Hiruta M; Tomiyama K; Kobayashi M; Tsuboi Y; Iwata K; Sumino R; Stephenson JD
    Eur J Pharmacol; 1989 Apr; 163(2-3):227-36. PubMed ID: 2566502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CCK-8 injected into the nucleus accumbens attenuates the supersensitive locomotor response to apomorphine in 6-OHDA and chronic-neuroleptic treated rats.
    Weiss F; Ettenberg A; Koob GF
    Psychopharmacology (Berl); 1989; 99(3):409-15. PubMed ID: 2574480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of dopamine D1 and D2 agonists and antagonists injected into the nucleus accumbens and globus pallidus on jaw movements of rats.
    Koshikawa N; Koshikawa F; Tomiyama K; Kikuchi de Beltrán K; Kamimura F; Kobayashi M
    Eur J Pharmacol; 1990 Jul; 182(2):375-80. PubMed ID: 1975784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The cholecystokinin analogue, caerulein, does not modulate dopamine release or dopamine-induced locomotor activity in the nucleus accumbens of rat.
    Hamilton M; Sheehan MJ; De Belleroche J; Herberg LJ
    Neurosci Lett; 1984 Jan; 44(1):77-82. PubMed ID: 6717857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ventral striatal vs. accumbal (shell) mechanisms and non-cyclase-coupled dopamine D(1)-like receptors in jaw movements.
    Hasegawa M; Adachi K; Nakamura S; Sato M; Waddington JL; Koshikawa N
    Eur J Pharmacol; 2001 Jul; 423(2-3):171-8. PubMed ID: 11448482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Behavioral evidence for the involvement of endogenous opioids in the interaction between cholecystokinin and brain dopamine systems.
    Király I; Van Ree JM
    Neurosci Lett; 1987 Mar; 74(3):343-7. PubMed ID: 3561887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. YM-14673, a thyrotropin-releasing hormone analogue, injected into the nucleus accumbens and the striatum produces repetitive jaw movements in rats.
    Miwa Y; Koshikawa N; Miyata N; Koshida Y; Kobayashi M; Cools AR
    Eur J Pharmacol; 1995 Apr; 277(1):63-9. PubMed ID: 7635174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Behavioral evidence for cholecystokinin modulation of dopamine in the mesolimbic pathway.
    Crawley JH
    Prog Clin Biol Res; 1985; 192():131-8. PubMed ID: 4080706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In rats, the behavioral profile of CCK-8 related peptides resembles that of antipsychotic agents.
    Van Ree JM; Gaffori O; De Wied D
    Eur J Pharmacol; 1983 Sep; 93(1-2):63-78. PubMed ID: 6138272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of GABA(A) receptors in the retrorubral field and ventral pallidum in rat jaw movements elicited by dopaminergic stimulation of the nucleus accumbens shell.
    Uchida T; Adachi K; Fujita S; Lee J; Gionhaku N; Cools AR; Koshikawa N
    Eur J Pharmacol; 2005 Mar; 510(1-2):39-47. PubMed ID: 15740723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence that angiotensin II enhances apomorphine-induced jaw movements via AT1 receptors in the ventrolateral striatum: studies by magnet-sensing system in freely moving rats.
    Lee J; Adachi K; Gionhaku N; Fujita S; Uchida T; Gerstner GE; Koshikawa N
    Methods Find Exp Clin Pharmacol; 2004 Apr; 26(3):195-9. PubMed ID: 15148525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extracellular dopamine in the anterior nucleus accumbens is distinctly affected by ventral tegmental area administration of cholecystokinin and apomorphine: data from in vivo voltammetry.
    Reum T; Fink H; Marsden CA; Morgenstern R
    Neuropeptides; 1998 Apr; 32(2):161-6. PubMed ID: 9639255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Behavioral interaction between endogenous opioids, CCK-8 and dopaminergic systems in the nucleus accumbens of rats.
    van Ree JM; Igarashi J; Király I
    NIDA Res Monogr; 1986; 75():323-6. PubMed ID: 2448632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cholecystokinin octapeptide (CCK-8) antagonizes morphine analgesia in nucleus accumbens of the rat via the CCK-B receptor.
    Pu SF; Zhuang HX; Han JS
    Brain Res; 1994 Sep; 657(1-2):159-64. PubMed ID: 7820614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo electrochemical analysis of cholecystokinin-induced inhibition of dopamine release in the nucleus accumbens.
    Lane RF; Blaha CD; Phillips AG
    Brain Res; 1986 Nov; 397(1):200-4. PubMed ID: 3801862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of caerulein and cholecystokinin-octapeptide on acetylcholine and choline contents in the brains of intact and vagotomized mice.
    Miyate H
    Pharmacol Biochem Behav; 1990 Jan; 35(1):143-9. PubMed ID: 2315352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.